European regulator recommends Pfizer’s Omicron booster for children

, ,
Pfizer logo

European regulator recommends Pfizer’s Omicron booster for children

Nov 10 (Reuters) – Pfizer Inc. (PFE.N) and its partner BioNTech said on Thursday the EU health regulator has recommended authorizing the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.

The Omicron-tailored vaccine is already authorized by the European Commission for individuals aged 12 years and above.

The updated bivalent booster shot targets the original coronavirus strain as well as the BA.4 and BA.5 sub-variants of Omicron.

n October, European Medical Agency backed authorization of Moderna Inc.’s (MRNA.O) COVID-19 tailored booster shots for 12 and above to further vaccination campaigns in the region.

Reporting by Bhanvi Satija and Khushi Mandowara in Bengaluru; Editing by Shounak Dasgupta amd Shinjini Ganguli

Our Standards: The Thomson Reuters Trust Principles.

Source: Reuters

/by
You might also like
MRI scan, brainBiogen secures Tecfidera exclusivity in EU until early 2025
PaxlovidPfizer donates Paxlovid to group targeting COVID in poorer countries
Pfizer BioNTech boosterTwo thirds of U.S. adults don’t plan on getting COVID boosters soon – poll
PaxlovidPfizer, BioNTech get legal pause in Moderna’s COVID-19 vaccine patent lawsuit
PfizerPfizer forecasts 24% COVID vaccination rate in US this year
GSK logoEU approves its first vaccine for common respiratory virus RSV
Pfizer logo illustrationU.S. to pay Pfizer nearly $2 billion for more Paxlovid courses in 2023
PaxlovidIn China, no easy way to get Pfizer’s COVID drug Paxlovid